Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Journal of Leukocyte Biology|April 19, 2000
Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesisD Nandan, K L Knutson, R Lo, et al.Annals of the New York Academy of Sciences|August 12, 1993
T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-ablM A Cheever, W Chen, M L Disis, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Induction of T cells specific for the mutated segment of oncogenic P21ras protein by immunization in vivo with the oncogenic proteinD J Peace, J W Smith, M L Disis, et al.Cancer Research|February 15, 1994
In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene proteinM L Disis, J W Smith, A E Murphy, et al.The Journal of Biological Chemistry|January 5, 1999
Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinaseZ Hmama, K L Knutson, P Herrera-Velit, et al.Cancer Research|March 1, 1995
Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral bloodH Bernhard, M L Disis, S Heimfeld, et al.The Journal of Biological Chemistry|February 7, 1998
Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1K L Knutson, Z Hmama, P Herrera-Velit, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancerM L Disis, S M Pupa, J R Gralow, et al.The Journal of Urology|October 12, 2000
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancerD G McNeel, L D Nguyen, B E Storer, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-proteinM L Disis, J R Gralow, H Bernhard, et al.Pageof 6